Selective Serotonin Reuptake Inhibitors: all 1,366 studies that test it
Page 11 of 14. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.
- Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00876772Phase 2/3
- Pharmacokinetics of Citalopram in Patients With Short Bowel SyndromeWithdrawnNCT00876226Not applicable
- Fluoxetine Essay in Children With AutismWithdrawnNCT00873834Phase 2
- Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major DepressionCompletedNCT00873795Not applicable
- A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in DepressionCompletedNCT00866593Phase 2/3
- A Relative Bioavailability Study of Citalopram HBr 10 mg Tablets Under Fasting ConditionsCompletedNCT00865943Phase 1
- A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fasting ConditionsCompletedNCT00865085Phase 1
- A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fed ConditionsCompletedNCT00864890Phase 1
- A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Fasting ConditionsCompletedNCT00864344Phase 1
- A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Non-fasting ConditionsCompletedNCT00864019Phase 1
- BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress DisorderCompletedNCT00839397Phase 3
- Role of Serotonin in Acute and Subacute MDMA EffectsCompletedNCT00838305Not applicable
- Cognitive Behavioural Analysis System of Psychotherapy (CBASp) Versus Escitalopram in Chronic DepressionStatus unknownNCT00837564Phase 3
- Sertraline Hydrochloride 100 mg Tablets, FastingCompletedNCT00836849Phase 1
- Sertraline Hydrochloride 100 mg Tablets, FedCompletedNCT00836667Phase 1
- Treatment Trial for Psychogenic Nonepileptic SeizuresCompletedNCT00835627Phase 4
- Haloperidol vs Olanzapine for the Management of ICU DeliriumTerminatedNCT00833300Not applicable
- Neurotrophic Factors and DepressionCompletedNCT00812994Phase 4
- Trazodone and Its Augmentation With Pregabalin in the Treatment of FibromyalgiaCompletedNCT00791739Phase 4
- Relapse-prevention Study With Lu AA21004 (Vortioxetine) in Patients With Generalized Anxiety DisorderCompletedNCT00788034Phase 3
- Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar DepressionCompletedNCT00787501Phase 1
- Extended Management and Measurement of AutismTerminatedNCT00787111Phase 3
- Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDDCompletedNCT00785434Phase 4
- Bioequivalence Study of Sertraline Hydrochloride 100mg Tablets Under Fasting ConditionsCompletedNCT00779350Not applicable
- Bioequivalence Study of Sertraline Hydrochloride 100mg Tablets Under Fed ConditionsCompletedNCT00778973Not applicable
- Bioequivalence Study of Fluoxetine HCL 40 mg Capsules Under Fasting ConditionsCompletedNCT00778024Not applicable
- Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic DisorderCompletedNCT00767871Phase 4
- Changes of Cerebral Glucose Metabolism After 12 Weeks of Paroxetine Treatment in Panic DisorderCompletedNCT00767754Phase 4
- A Study in the Treatment of Acute ManiaTerminatedNCT00767715Phase 4
- PAXIL CR Bioequivalence StudyCompletedNCT00749359Phase 1
- Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer PainWithdrawnNCT00737191Not applicable
- Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest PainStatus unknownNCT00736346Not applicable
- Treatment of Post-traumatic Stress Disorder With High Doses of EscitalopramCompletedNCT00736021Not applicable
- Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic SubjectsTerminatedNCT00734435Phase 2
- Comparison of Effects Between Conventional Dose and High Dose Escitalopram on Clinical Improvement in Patients With Obsessive-compulsive DisorderCompletedNCT00723060Phase 4
- Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety DisorderCompletedNCT00715039Not applicable
- Fluoxetine vs. Brief Psychotherapy for Major DepressionCompletedNCT00714779Not applicable
- Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute SchizophreniaCompletedNCT00712686Phase 3
- Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label StudyStatus unknownNCT00708396Phase 4
- Treatment Youth With Obsessive-Compulsive DisorderStatus unknownNCT00708240Phase 4
- A Neuroimaging and Epigenetic Investigation of Antidepressants in DepressionCompletedNCT00703742Not applicable
- Prophylactic Olanzapine Versus Placebo for Prevention of Postoperative Delirium After Joint Replacement SurgeryCompletedNCT00699946Not applicable
- International Study to Predict Optimised Treatment - in DepressionStatus unknownNCT00693849Phase 4
- Validation of Surrogate Measures in Irritable Bowel Syndrome (IBS)CompletedNCT00693732Phase 4
- TC-5214 as add-on the Treatment of Major Depressive DisorderCompletedNCT00692445Phase 2
- The Effect of Escitalopram on the Pharmacokinetics and Pharmacodynamics of Tramadol in Healthy SubjectsCompletedNCT00692263Phase 4
- Ondansetron With Olanzapine for the Treatment of Alcohol Dependence: A Preliminary Clinical TrialCompletedNCT00678457Phase 2
- Comparison of the Pharmacokinetics of Two Generic Antidepressants and Their Respective Brand PreparationsCompletedNCT00676039Phase 1
- Effects of Paxil CR on Neural Circuits in Posttraumatic Stress Disorder (PTSD)CompletedNCT00672776Phase 4
- Pipamperone/Citalopram (PipCit)Versus Citalopram in the Treatment of Major Depressive Disorder(MDD)CompletedNCT00672659Phase 2
- Cardio Risk of Acute Schizophrenia Olanzapine DukeWithdrawnNCT00672464Phase 4
- Neural Correlates of Early Intervention for Posttraumatic Stress Disorder (PTSD)TerminatedNCT00665678Phase 4
- Relapse Prevention With Escitalopram or Nortriptyline Following Electro-Convulsive Treatment (DUAG-7)TerminatedNCT00660062Phase 4
- Treatment of Neuroleptic Induced Acute Akathisia With TrazodoneCompletedNCT00659919Phase 4
- Fluoxetine on Motor Rehabilitation After Ischemic StrokeCompletedNCT00657163Phase 2
- Safety and Efficacy of Escitalopram in the Treatment of Premature EjaculationStatus unknownNCT00656552Early Phase 1
- Fluvoxamine and Sertraline in Childhood Autism - Does SSRI Therapy Improve Behaviour and/or Mood?CompletedNCT00655174Phase 3
- Efficacy Study of Escitalopram for Depression in Patients With DiabetesStatus unknownNCT00650897Phase 4
- Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mgCompletedNCT00650403Phase 1
- Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mgCompletedNCT00650325Phase 1
- Fasting Study of Fluoxetine Capsules 40 mg and Prozac Pulvules 40 mgCompletedNCT00649636Phase 1
- Fasting Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mgCompletedNCT00648921Phase 1
- Food Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mgCompletedNCT00648856Phase 1
- Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mgCompletedNCT00648661Phase 1
- Fasting Study of Escitalopram Oxalate Tablets 20 mg and Lexapro® Tablets 20 mgCompletedNCT00648570Phase 1
- Fasting Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mgCompletedNCT00648193Early Phase 1
- Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mgTerminatedNCT00647972Phase 1
- Food Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mgCompletedNCT00647777Phase 1
- Genetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive FunctionStatus unknownNCT00645580Not applicable
- A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major DepressionCompletedNCT00644982Phase 4
- Early Intervention for Post Traumatic Stress Disorder (PTSD)WithdrawnNCT00641173Not applicable
- Effects of Modafinil on Olanzapine Weight GainCompletedNCT00636896Not applicable
- A Comparison of Sertraline-reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression.CompletedNCT00636246Phase 2
- Predictors of Treatment Response to Fluoxetine in PTSD Following a Recent History of War Zone Stress ExposureStatus unknownNCT00633685Phase 4
- Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and TiaprideCompletedNCT00632645Phase 3
- An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive DisorderCompletedNCT00629551Phase 3
- Brain Mechanisms and Targeting Insomnia in Major DepressionStatus unknownNCT00628914Phase 4
- Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive DyskinesiaCompletedNCT00621998Phase 4
- Behavioral Insomnia Therapy For Those With Insomnia and DepressionStatus unknownNCT00620789Not applicable
- Pharmacodynamics and Pharmacokinetics of Citalopram and EscitalopramCompletedNCT00613470Phase 1
- ERP N1 as a Treatment Predictor of Generalized Anxiety DisorderCompletedNCT00613067Not applicable
- Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)CompletedNCT00610909Phase 4
- Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia SyndromeCompletedNCT00610610Phase 4
- Escitalopram (Lexapro®) In Patients With Major Depression With Atypical FeaturesCompletedNCT00610506Phase 3
- Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum DisordersCompletedNCT00609531Phase 1
- Bioequivalency Study of Sertraline Under Fasting ConditionsCompletedNCT00602849Not applicable
- Bioequivalency Study of Sertraline Under Fed ConditionsCompletedNCT00601588Not applicable
- Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior TherapyStatus unknownNCT00598052Not applicable
- Escitalopram Treatment of Major Depression in Patients With Temporal Lobe EpilepsyCompletedNCT00595699Phase 4
- Olanzapine in the Treatment of Anorexia NervosaCompletedNCT00592930Phase 4
- Hypoglycemia Associated Autonomic Failure in Type 1 DMCompletedNCT00592670Not applicable
- Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal DiseaseWithdrawnNCT00573547Phase 4
- Optimal Duration of Olanzapine Add-on Therapy in Major DepressionWithdrawnNCT00568672Phase 3
- Efficacy of Escitalopram in the Treatment of Internet AddictionCompletedNCT00565422Phase 4
- Pharmacokinetic and Pharmacodynamic Effects of Escitalopram Depending on Genetic Polymorphisms of the ABCB1-geneCompletedNCT00550485Not applicable
- Study Evaluating a Combined Administration of Lecozotan SR and Citalopram in Young Healthy SubjectsCompletedNCT00538889Phase 1
- Metabolic Profile and Anthropometric Changes in SchizophreniaCompletedNCT00534183Not applicable
- Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo NodularisStatus unknownNCT00532519Not applicable
- An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive DisorderCompletedNCT00531622Phase 3
- An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed PatientsCompletedNCT00520507Phase 4